WGCA
BMY icon

Wolf Group Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Wolf Group Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.35M Sell
22,159
-1,308
-6% -$76.2K 0.45% 70
2024
Q4 		$1.5M Hold
23,467
– – 0.73% 54
2024
Q3 		$1.5M Sell
23,467
-1,631
-6% -$76.5K 0.71% 55
2024
Q2 		$1.04M Buy
25,098
+1,631
+7% +$73K 0.41% 71
2024
Q1 		$1.5M Hold
23,467
– – 0.71% 55
2023
Q4 		$1.5M Buy
23,467
+260
+1% +$13.6K 0.71% 55
2023
Q3 		$1.35M Sell
23,207
-95
-0.4% -$5.82K 0.64% 59
2023
Q2 		$1.51M Sell
23,302
-395
-2% -$26.5K 0.75% 48
2023
Q1 		$1.64M Sell
23,697
-2,775
-10% -$196K 0.82% 46
2022
Q4 		$1.9M Sell
26,472
-1,918
-7% -$145K 0.9% 39
2022
Q3 		$2.02M Sell
28,390
-20
-0.1% -$1.45K 1.11% 29
2022
Q2 		$2.19M Sell
28,410
-3,800
-12% -$289K 1.14% 30
2022
Q1 		$2.35M Sell
32,210
-65,815
-67% -$4.42M 1.2% 27
2021
Q4 		$6.11M Buy
98,025
+65,912
+205% +$3.87M 1% 35
2021
Q3 		$1.9M Sell
32,113
-528
-2% -$34.8K 1.04% 30
2021
Q2 		$2.18M Buy
32,641
+114
+0.4% +$7.43K 1.17% 26
2021
Q1 		$2.05M Buy
32,527
+931
+3% +$57.9K 1.18% 29
2020
Q4 		$1.96M Sell
31,596
-107
-0.3% -$6.58K 1.21% 29
2020
Q3 		$1.91M Buy
31,703
+33
+0.1% +$1.99K 1.33% 24
2020
Q2 		$1.86M Buy
31,670
+1,819
+6% +$109K 1.39% 25
2020
Q1 		$1.66M Buy
29,851
+1,175
+4% +$71.8K 1.39% 29
2019
Q4 		$1.84M Buy
28,676
+6,302
+28% +$361K 1.21% 34
2019
Q3 		$1.14M Buy
22,374
+16,810
+302% +$790K 0.78% 45
2019
Q2 		$252K Buy
+5,564
New +$259K 0.17% 74

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wolf Group Capital Advisors's BMY Position: Q1 2025 in Review

Wolf Group Capital Advisors reduced its Bristol-Myers Squibb (BMY) stake by 5.6% in Q1 2025, selling an estimated $76.2K and leaving 22,159 shares worth $1.35M. The position accounts for 0.45% of the portfolio, ranked #70.

Wolf Group Capital Advisors first reported a position in BMY in Q2 2019 and has held it in 24 quarters since. The position peaked at $6.11M in Q4 2021. 2,478 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • Wolf Group Capital Advisors held 22,159 shares of Bristol-Myers Squibb worth $1.35M as of Q1 2025.
  • Wolf Group Capital Advisors sold 1,308 Bristol-Myers Squibb shares in Q1 2025, an estimated $76.2K.
  • Bristol-Myers Squibb made up 0.45% of Wolf Group Capital Advisors's portfolio in Q1 2025, its #70 holding.
  • Wolf Group Capital Advisors first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 24 quarters since.
  • Wolf Group Capital Advisors's Bristol-Myers Squibb position peaked at $6.11M in Q4 2021.
  • 2,478 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Wolf Group Capital Advisors's 13F filing for Q1 2025, filed 18 Apr 2025.